Irras AB engages in the development, design, and commercialization of solutions for the treatment of brain pathologies. It offers IRRAflow, an integrated, closed-circuit medical device system that enables controlled management of cerebrospinal fluid (CSF) while providing continual monitoring of intracranial pressure (ICP). The company was founded by Christos Panotopoulos in 2012 and is headquartered in Stockholm, Sweden.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Irras AB?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Irras AB market cap is $181.75M.